Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is cystatin C more effective than creatinine in predicting adverse cardiovascular outcomes in elderly people?

Nature Clinical Practice Nephrology volume 1, pages 8–9 (2005)Cite this article

boxed-textShlipak MG et al. (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352: 2049–2060

Even early signs of renal insufficiency indicate an increased risk of stroke, myocardial infarction or congestive heart failure; treatment in such cases should be directed at reducing proteinuria

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Engl J Med 351: 1344–1346

    Article  CAS  Google Scholar 

  2. Go AS et al. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296–1305

    Article  CAS  Google Scholar 

  3. Mann JF et al. (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134: 629–636

    Article  CAS  Google Scholar 

  4. De Zeeuw D et al. (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110: 921–927

    Article  CAS  Google Scholar 

  5. Sjostrom P et al. (2005) Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 65: 111–124

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. a post-doctoral fellow in Nephrology at the University of Texas Medical Branch, Galveston

    Sreedhar Mandayam

  2. the Gordon A Cain Professor of Medicine and Director of the Nephrology Division at Baylor College of Medicine, Houston, TX, USA

    William E Mitch

Authors
  1. Sreedhar Mandayam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William E Mitch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William E Mitch.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mandayam, S., Mitch, W. Is cystatin C more effective than creatinine in predicting adverse cardiovascular outcomes in elderly people?. Nat Rev Nephrol 1, 8–9 (2005). https://doi.org/10.1038/ncpneph0026

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0026

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing